Indoco Remedies Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹445.36 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 8.11 per cent from ₹484.67 crore. This corresponds to a year-on-year *(YoY) growth of 8.48 per cent.
Operating Profit
Operating Profit stands at ₹25.36 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 40.36 per cent from ₹42.52 crore. This corresponds to a year-on-year *(YoY) growth of 110.81 per cent.
PBDT
PBDT stands at ₹0.70 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 96.26 per cent from ₹18.72 crore. This corresponds to a year-on-year *(YoY) growth of 131.25 per cent.
Profit Before Tax
Profit Before Tax stands at ₹-31.31 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 131.41 per cent from ₹-13.53 crore. This corresponds to a year-on-year *(YoY) decline of 1.13 per cent.
Net Profit
Net Profit stands at ₹-29.45 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 219.76 per cent from ₹-9.21 crore. This represents a 3.70 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Indoco Remedies Ltd Earnings
- YOY
- QOQ
Indoco Remedies Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Indoco Remedies Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Indoco Remedies Ltd Financial Reports
Indoco Remedies Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Indoco Remedies | 0.87% | 4.79% | 13.31% | 2.73% | -23.38% | -9.15% |
| Morepen Labs. | 0.48% | 3.39% | 7.32% | 12.32% | -14.24% | -23.00% |
| Panacea Biotec | 1.21% | 8.20% | 4.95% | -8.62% | -17.40% | -29.46% |
| Sai Parenteral's | 3.84% | 14.27% | 20.08% | 20.08% | 20.08% | 20.08% |
| Titan Biotech | 5.00% | 15.76% | 23.11% | 135.23% | 91.53% | 380.80% |
| Solara Active | 3.31% | 3.63% | 12.92% | -5.20% | -14.66% | -3.10% |
| Windlas Biotech | -0.97% | 6.22% | 17.92% | 1.65% | -8.34% | -19.01% |
Company Info
Company Information
Chairman & Non Executive Dir. : Suresh G Kare
ED / MD / Promoter : Aditi Kare Panandikar
Joint MD & Executive Director : Sundeep V Bambolkar
Non-Exec & Non-Independent Dir : Anand Nadkarni
Independent Non Exe. Director : Satish Shenoy
Independent Non Exe. Director : Ajay Mulgaokar
Independent Non Exe. Director : Vasudha V Kamat
Independent Non Exe. Director : Abhijit Y Gore
CS / Compliance Officer / Legal Head : RAMANATHAN HARIHARAN